It is a pharma private limited company based in New Delhi, Delhi, India, established in 2009.
2009 | New Delhi, Delhi, India | ActiveEverest Pharmakon Private Limited, a active private limited company, was established on 19 October 2009 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24230DL2009PTC195326. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Hem Lata Chaubey (Director), Jai Prakash Chaubey (Director), Babita Chaubey (Director). Past directors included Ramesh Khatiwada Kumar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 24, Metro Apparment Dda(Sfs) Flats, Poket- 8, Sector-13, Dwa, Rka, New Delhi, Delhi, 110075.
U24230DL2009PTC195326
195326
19 October 2009
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Everest Pharmakon Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hem Lata Chaubey | Director | 19 Oct 2009 | Current |
| Jai Prakash Chaubey | Director | 12 Nov 2009 | Current |
| Babita Chaubey | Director | 07 May 2024 | Current |
| Uma Pandey | Director | 07 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2014 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Everest Pharmakon Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 135.66% decrease in profit. The company's net worth dipped by a decrease of 1.76%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Everest Pharmakon's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Everest Pharmakon, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Everest Pharmakon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Everest Pharmakon's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Everest Pharmakon Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Babita Chaubey was appointed as a Director was appointed as a Director on 07 May 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
The activity Uma Pandey was appointed as a Director was appointed as a Director on 07 May 2024 & has been associated with this company since 1 year 7 months . was completed.
The activity Everest Pharmakon Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was completed.
Jai Prakash Chaubey was appointed as a Director was appointed as a Director on 12 Nov 2009 & has been associated with this company since 16 years 1 month . was recorded as a recent event.
Progress on Hem Lata Chaubey was appointed as a Director was appointed as a Director on 19 Oct 2009 & has been associated with this company since 16 years 2 months . was documented.
The CIN of Everest Pharmakon Private Limited is U24230DL2009PTC195326.
Everest Pharmakon Private Limited is headquartered at 24, Metro Apparment Dda(Sfs) Flats, Poket- 8, Sector-13, Dwa, Rka, New Delhi, Delhi, 110075.
Everest Pharmakon Private Limited was incorporated on 19 October 2009.
The current directors of Everest Pharmakon Private Limited are
The primary industry of Everest Pharmakon Private Limited is Manufacturing.
Everest Pharmakon Private Limited is unlisted.
The authorized capital of Everest Pharmakon Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Everest Pharmakon Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX